Valuation: Clene Inc.

Market Cap 75.65M 66.11M 61M 56.23M 106M 7.28B 108M 729M 287M 3.57B 284M 278M 12.28B P/E 2026 *
-3.31x
P/E 2027 * -4.02x
Enterprise Value 62.25M 54.4M 50.2M 46.27M 87.21M 5.99B 89.14M 600M 236M 2.94B 234M 229M 10.11B EV / Sales 2026 *
300x
EV / Sales 2027 * 2.29x
Free-Float
82.94%
Yield 2026 *
-
Yield 2027 * -
1 day+4.04%
1 week-5.58%
Current month-3.82%
1 month-1.50%
3 months-6.18%
6 months+17.23%
Current year+0.85%
1 week 5.57
Extreme 5.5701
6.55
1 month 5.57
Extreme 5.5701
6.55
Current year 3.88
Extreme 3.88
8.67
1 year 3.25
Extreme 3.25
13.5
3 years 2.28
Extreme 2.2801
16.36
5 years 2.28
Extreme 2.2801
196.8
10 years 2.28
Extreme 2.2801
356.4
Manager TitleAgeSince
Chief Executive Officer 59 01/04/2013
Chief Tech/Sci/R&D Officer 67 01/01/2013
Director of Finance/CFO 57 01/02/2022
Director TitleAgeSince
Director/Board Member 78 01/03/2013
Chairman 65 19/05/2021
Director/Board Member 49 01/12/2020
Date Insider Type Main position Quantity % Market Cap.
11/6/26 Free

Chief Financial Officer

15,000 0.1174%
11/6/26 Free

Chief Executive Officer

65,000 0.5087%
11/6/26 Free

Founder

45,000 0.3522%
Change 5-day change 1-year change 3-year change Capi.($)
+4.04%-5.58%+54.97%-63.46% 75.65M
+0.24%-1.54%+52.85%+71.85% 53.83B
-7.17%-4.39%+42.72%+73.32% 52.1B
+0.80%-6.31%+5.62%+417.78% 23.48B
-0.09%-0.01%-16.85%-15.41% 23.13B
-5.95%-2.58%+29.53%-9.47% 19.36B
-1.14%+0.03%+31.67%-30.65% 17.56B
-5.16%-7.00%+168.44%+314.96% 15.2B
-6.91%-5.83%+25.17%+644.30% 14.83B
+0.43%-1.03%+25.75%+189.74% 14.06B
Average -2.09%-2.92%+41.99%+159.30% 23.36B
Weighted average by Cap. -2.80%-2.36%+39.55%+143.06%

Financials

2026 *2027 *
Net sales 207K 181K 167K 154K 291K 19.97M 297K 2M 786K 9.78M 779K 762K 33.67M 23.64M 20.66M 19.07M 17.57M 33.13M 2.28B 33.86M 228M 89.64M 1.12B 88.8M 86.85M 3.84B
Net income -25.09M -21.93M -20.24M -18.65M -35.16M -2.42B -35.94M -242M -95.13M -1.18B -94.24M -92.17M -4.07B -27.55M -24.07M -22.21M -20.48M -38.59M -2.65B -39.45M -266M -104M -1.3B -103M -101M -4.47B
Net Debt -13.4M -11.71M -10.81M -9.96M -18.77M -1.29B -19.19M -129M -50.8M -632M -50.32M -49.22M -2.18B -21.4M -18.7M -17.26M -15.91M -29.98M -2.06B -30.65M -206M -81.13M -1.01B -80.37M -78.6M -3.47B
Logo Clene Inc.
Clene Inc. is a clinical-stage pharmaceutical company, which is engaged in discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The CSN therapeutics are comprised of atoms of transition elements that, when assembled in nanocrystal form, possess unusually high, unique catalytic activities that do not present in those same elements in bulk form. CNM-Au8, the lead drug asset, is a concentrated aqueous suspension of catalytically active, clean-surfaced, faceted gold nanocrystals for the treatment of ALS, MS, and PD. CNM-Au8's mechanism of action targets mitochondrial dysfunction by catalyzing the production of nicotinamide adenine dinucleotide. Its CNM-ZnAg is an antiviral and antibacterial agent comprised of zinc (Zn2+) and silver (Ag+) ions in an aqueous solution to treat infectious disease and to provide immune support for symptom resolution.
Employees
78
Date Price Change Volume
17/07/26 USD 5.920 +4.04% 83,174
16/07/26 USD 5.690 -5.48% 97,068
15/07/26 USD 6.020 -2.75% 53,979
14/07/26 USD 6.190 -3.13% 73,125
13/07/26 USD 6.390 +1.91% 72,591
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
5.920USD
Average target price
32.20USD
Spread / Average Target
+443.92%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CLNN Stock